Global Immuno-oncology Drugs Market Research Report 2023

Global Immuno-oncology Drugs Market Research Report 2023

Table of Contents
1 Immuno-oncology Drugs Market Overview
1.1 Product Overview and Scope of Immuno-oncology Drugs
1.2 Immuno-oncology Drugs Segment by Type
1.2.1 Global Immuno-oncology Drugs Market Value Comparison by Type (2023-2029)
1.2.2 Immune Checkpoint Inhibitors
1.2.3 Immune System Modulators
1.2.4 Cancer Vaccines
1.2.5 Oncolytic Virus
1.2.6 Others
1.3 Immuno-oncology Drugs Segment by Application
1.3.1 Global Immuno-oncology Drugs Market Value by Application: (2023-2029)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Ambulatory Surgical Centers
1.4 Global Immuno-oncology Drugs Market Size Estimates and Forecasts
1.4.1 Global Immuno-oncology Drugs Revenue 2018-2029
1.4.2 Global Immuno-oncology Drugs Sales 2018-2029
1.4.3 Global Immuno-oncology Drugs Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Immuno-oncology Drugs Market Competition by Manufacturers
2.1 Global Immuno-oncology Drugs Sales Market Share by Manufacturers (2018-2023)
2.2 Global Immuno-oncology Drugs Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Immuno-oncology Drugs Average Price by Manufacturers (2018-2023)
2.4 Global Immuno-oncology Drugs Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Immuno-oncology Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Immuno-oncology Drugs, Product Type & Application
2.7 Immuno-oncology Drugs Market Competitive Situation and Trends
2.7.1 Immuno-oncology Drugs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Immuno-oncology Drugs Players Market Share by Revenue
2.7.3 Global Immuno-oncology Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Immuno-oncology Drugs Retrospective Market Scenario by Region
3.1 Global Immuno-oncology Drugs Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Immuno-oncology Drugs Global Immuno-oncology Drugs Sales by Region: 2018-2029
3.2.1 Global Immuno-oncology Drugs Sales by Region: 2018-2023
3.2.2 Global Immuno-oncology Drugs Sales by Region: 2024-2029
3.3 Global Immuno-oncology Drugs Global Immuno-oncology Drugs Revenue by Region: 2018-2029
3.3.1 Global Immuno-oncology Drugs Revenue by Region: 2018-2023
3.3.2 Global Immuno-oncology Drugs Revenue by Region: 2024-2029
3.4 North America Immuno-oncology Drugs Market Facts & Figures by Country
3.4.1 North America Immuno-oncology Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Immuno-oncology Drugs Sales by Country (2018-2029)
3.4.3 North America Immuno-oncology Drugs Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Immuno-oncology Drugs Market Facts & Figures by Country
3.5.1 Europe Immuno-oncology Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Immuno-oncology Drugs Sales by Country (2018-2029)
3.5.3 Europe Immuno-oncology Drugs Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Immuno-oncology Drugs Market Facts & Figures by Country
3.6.1 Asia Pacific Immuno-oncology Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Immuno-oncology Drugs Sales by Country (2018-2029)
3.6.3 Asia Pacific Immuno-oncology Drugs Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Immuno-oncology Drugs Market Facts & Figures by Country
3.7.1 Latin America Immuno-oncology Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Immuno-oncology Drugs Sales by Country (2018-2029)
3.7.3 Latin America Immuno-oncology Drugs Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Immuno-oncology Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Immuno-oncology Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Immuno-oncology Drugs Sales by Country (2018-2029)
3.8.3 Middle East and Africa Immuno-oncology Drugs Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Immuno-oncology Drugs Sales by Type (2018-2029)
4.1.1 Global Immuno-oncology Drugs Sales by Type (2018-2023)
4.1.2 Global Immuno-oncology Drugs Sales by Type (2024-2029)
4.1.3 Global Immuno-oncology Drugs Sales Market Share by Type (2018-2029)
4.2 Global Immuno-oncology Drugs Revenue by Type (2018-2029)
4.2.1 Global Immuno-oncology Drugs Revenue by Type (2018-2023)
4.2.2 Global Immuno-oncology Drugs Revenue by Type (2024-2029)
4.2.3 Global Immuno-oncology Drugs Revenue Market Share by Type (2018-2029)
4.3 Global Immuno-oncology Drugs Price by Type (2018-2029)
5 Segment by Application
5.1 Global Immuno-oncology Drugs Sales by Application (2018-2029)
5.1.1 Global Immuno-oncology Drugs Sales by Application (2018-2023)
5.1.2 Global Immuno-oncology Drugs Sales by Application (2024-2029)
5.1.3 Global Immuno-oncology Drugs Sales Market Share by Application (2018-2029)
5.2 Global Immuno-oncology Drugs Revenue by Application (2018-2029)
5.2.1 Global Immuno-oncology Drugs Revenue by Application (2018-2023)
5.2.2 Global Immuno-oncology Drugs Revenue by Application (2024-2029)
5.2.3 Global Immuno-oncology Drugs Revenue Market Share by Application (2018-2029)
5.3 Global Immuno-oncology Drugs Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Amgen, Inc
6.1.1 Amgen, Inc Corporation Information
6.1.2 Amgen, Inc Description and Business Overview
6.1.3 Amgen, Inc Immuno-oncology Drugs Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Amgen, Inc Immuno-oncology Drugs Product Portfolio
6.1.5 Amgen, Inc Recent Developments/Updates
6.2 AstraZeneca, Plc
6.2.1 AstraZeneca, Plc Corporation Information
6.2.2 AstraZeneca, Plc Description and Business Overview
6.2.3 AstraZeneca, Plc Immuno-oncology Drugs Sales, Revenue and Gross Margin (2018-2023)
6.2.4 AstraZeneca, Plc Immuno-oncology Drugs Product Portfolio
6.2.5 AstraZeneca, Plc Recent Developments/Updates
6.3 Bristol-Myers Squibb
6.3.1 Bristol-Myers Squibb Corporation Information
6.3.2 Bristol-Myers Squibb Description and Business Overview
6.3.3 Bristol-Myers Squibb Immuno-oncology Drugs Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Bristol-Myers Squibb Immuno-oncology Drugs Product Portfolio
6.3.5 Bristol-Myers Squibb Recent Developments/Updates
6.4 Celgene Corporation
6.4.1 Celgene Corporation Corporation Information
6.4.2 Celgene Corporation Description and Business Overview
6.4.3 Celgene Corporation Immuno-oncology Drugs Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Celgene Corporation Immuno-oncology Drugs Product Portfolio
6.4.5 Celgene Corporation Recent Developments/Updates
6.5 Eli Lilly and Company
6.5.1 Eli Lilly and Company Corporation Information
6.5.2 Eli Lilly and Company Description and Business Overview
6.5.3 Eli Lilly and Company Immuno-oncology Drugs Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Eli Lilly and Company Immuno-oncology Drugs Product Portfolio
6.5.5 Eli Lilly and Company Recent Developments/Updates
6.6 Merck & Co.
6.6.1 Merck & Co. Corporation Information
6.6.2 Merck & Co. Description and Business Overview
6.6.3 Merck & Co. Immuno-oncology Drugs Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Merck & Co. Immuno-oncology Drugs Product Portfolio
6.6.5 Merck & Co. Recent Developments/Updates
6.7 Hoffmann-La Roche AG
6.6.1 Hoffmann-La Roche AG Corporation Information
6.6.2 Hoffmann-La Roche AG Description and Business Overview
6.6.3 Hoffmann-La Roche AG Immuno-oncology Drugs Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Hoffmann-La Roche AG Immuno-oncology Drugs Product Portfolio
6.7.5 Hoffmann-La Roche AG Recent Developments/Updates
6.8 Johnson & Johnson
6.8.1 Johnson & Johnson Corporation Information
6.8.2 Johnson & Johnson Description and Business Overview
6.8.3 Johnson & Johnson Immuno-oncology Drugs Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Johnson & Johnson Immuno-oncology Drugs Product Portfolio
6.8.5 Johnson & Johnson Recent Developments/Updates
6.9 Novartis International AG
6.9.1 Novartis International AG Corporation Information
6.9.2 Novartis International AG Description and Business Overview
6.9.3 Novartis International AG Immuno-oncology Drugs Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Novartis International AG Immuno-oncology Drugs Product Portfolio
6.9.5 Novartis International AG Recent Developments/Updates
6.10 AbbVie, Inc.
6.10.1 AbbVie, Inc. Corporation Information
6.10.2 AbbVie, Inc. Description and Business Overview
6.10.3 AbbVie, Inc. Immuno-oncology Drugs Sales, Revenue and Gross Margin (2018-2023)
6.10.4 AbbVie, Inc. Immuno-oncology Drugs Product Portfolio
6.10.5 AbbVie, Inc. Recent Developments/Updates
6.11 Pfizer Inc.
6.11.1 Pfizer Inc. Corporation Information
6.11.2 Pfizer Inc. Immuno-oncology Drugs Description and Business Overview
6.11.3 Pfizer Inc. Immuno-oncology Drugs Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Pfizer Inc. Immuno-oncology Drugs Product Portfolio
6.11.5 Pfizer Inc. Recent Developments/Updates
6.12 Sanofi S.A.
6.12.1 Sanofi S.A. Corporation Information
6.12.2 Sanofi S.A. Immuno-oncology Drugs Description and Business Overview
6.12.3 Sanofi S.A. Immuno-oncology Drugs Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Sanofi S.A. Immuno-oncology Drugs Product Portfolio
6.12.5 Sanofi S.A. Recent Developments/Updates
6.13 EMD Serono, Inc.
6.13.1 EMD Serono, Inc. Corporation Information
6.13.2 EMD Serono, Inc. Immuno-oncology Drugs Description and Business Overview
6.13.3 EMD Serono, Inc. Immuno-oncology Drugs Sales, Revenue and Gross Margin (2018-2023)
6.13.4 EMD Serono, Inc. Immuno-oncology Drugs Product Portfolio
6.13.5 EMD Serono, Inc. Recent Developments/Updates
6.14 Gilead Sciences Inc.
6.14.1 Gilead Sciences Inc. Corporation Information
6.14.2 Gilead Sciences Inc. Immuno-oncology Drugs Description and Business Overview
6.14.3 Gilead Sciences Inc. Immuno-oncology Drugs Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Gilead Sciences Inc. Immuno-oncology Drugs Product Portfolio
6.14.5 Gilead Sciences Inc. Recent Developments/Updates
6.15 Prometheus Therapeutics & Diagnostics
6.15.1 Prometheus Therapeutics & Diagnostics Corporation Information
6.15.2 Prometheus Therapeutics & Diagnostics Immuno-oncology Drugs Description and Business Overview
6.15.3 Prometheus Therapeutics & Diagnostics Immuno-oncology Drugs Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Prometheus Therapeutics & Diagnostics Immuno-oncology Drugs Product Portfolio
6.15.5 Prometheus Therapeutics & Diagnostics Recent Developments/Updates
6.16 Aduro BioTech
6.16.1 Aduro BioTech Corporation Information
6.16.2 Aduro BioTech Immuno-oncology Drugs Description and Business Overview
6.16.3 Aduro BioTech Immuno-oncology Drugs Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Aduro BioTech Immuno-oncology Drugs Product Portfolio
6.16.5 Aduro BioTech Recent Developments/Updates
6.17 Galena Biopharma
6.17.1 Galena Biopharma Corporation Information
6.17.2 Galena Biopharma Immuno-oncology Drugs Description and Business Overview
6.17.3 Galena Biopharma Immuno-oncology Drugs Sales, Revenue and Gross Margin (2018-2023)
6.17.4 Galena Biopharma Immuno-oncology Drugs Product Portfolio
6.17.5 Galena Biopharma Recent Developments/Updates
6.18 Bavarian Nordic
6.18.1 Bavarian Nordic Corporation Information
6.18.2 Bavarian Nordic Immuno-oncology Drugs Description and Business Overview
6.18.3 Bavarian Nordic Immuno-oncology Drugs Sales, Revenue and Gross Margin (2018-2023)
6.18.4 Bavarian Nordic Immuno-oncology Drugs Product Portfolio
6.18.5 Bavarian Nordic Recent Developments/Updates
6.19 Celldex Therapeutics
6.19.1 Celldex Therapeutics Corporation Information
6.19.2 Celldex Therapeutics Immuno-oncology Drugs Description and Business Overview
6.19.3 Celldex Therapeutics Immuno-oncology Drugs Sales, Revenue and Gross Margin (2018-2023)
6.19.4 Celldex Therapeutics Immuno-oncology Drugs Product Portfolio
6.19.5 Celldex Therapeutics Recent Developments/Updates
6.20 ImmunoCellular Therapeutics
6.20.1 ImmunoCellular Therapeutics Corporation Information
6.20.2 ImmunoCellular Therapeutics Immuno-oncology Drugs Description and Business Overview
6.20.3 ImmunoCellular Therapeutics Immuno-oncology Drugs Sales, Revenue and Gross Margin (2018-2023)
6.20.4 ImmunoCellular Therapeutics Immuno-oncology Drugs Product Portfolio
6.20.5 ImmunoCellular Therapeutics Recent Developments/Updates
6.21 Incyte
6.21.1 Incyte Corporation Information
6.21.2 Incyte Immuno-oncology Drugs Description and Business Overview
6.21.3 Incyte Immuno-oncology Drugs Sales, Revenue and Gross Margin (2018-2023)
6.21.4 Incyte Immuno-oncology Drugs Product Portfolio
6.21.5 Incyte Recent Developments/Updates
6.22 Dendreon Corporation
6.22.1 Dendreon Corporation Corporation Information
6.22.2 Dendreon Corporation Immuno-oncology Drugs Description and Business Overview
6.22.3 Dendreon Corporation Immuno-oncology Drugs Sales, Revenue and Gross Margin (2018-2023)
6.22.4 Dendreon Corporation Immuno-oncology Drugs Product Portfolio
6.22.5 Dendreon Corporation Recent Developments/Updates
6.23 Agilent Technologies Inc.
6.23.1 Agilent Technologies Inc. Corporation Information
6.23.2 Agilent Technologies Inc. Immuno-oncology Drugs Description and Business Overview
6.23.3 Agilent Technologies Inc. Immuno-oncology Drugs Sales, Revenue and Gross Margin (2018-2023)
6.23.4 Agilent Technologies Inc. Immuno-oncology Drugs Product Portfolio
6.23.5 Agilent Technologies Inc. Recent Developments/Updates
6.24 Agenus Inc.
6.24.1 Agenus Inc. Corporation Information
6.24.2 Agenus Inc. Immuno-oncology Drugs Description and Business Overview
6.24.3 Agenus Inc. Immuno-oncology Drugs Sales, Revenue and Gross Margin (2018-2023)
6.24.4 Agenus Inc. Immuno-oncology Drugs Product Portfolio
6.24.5 Agenus Inc. Recent Developments/Updates
6.25 Enzo Biochem, Inc.
6.25.1 Enzo Biochem, Inc. Corporation Information
6.25.2 Enzo Biochem, Inc. Immuno-oncology Drugs Description and Business Overview
6.25.3 Enzo Biochem, Inc. Immuno-oncology Drugs Sales, Revenue and Gross Margin (2018-2023)
6.25.4 Enzo Biochem, Inc. Immuno-oncology Drugs Product Portfolio
6.25.5 Enzo Biochem, Inc. Recent Developments/Updates
6.26 Lonza Group
6.26.1 Lonza Group Corporation Information
6.26.2 Lonza Group Immuno-oncology Drugs Description and Business Overview
6.26.3 Lonza Group Immuno-oncology Drugs Sales, Revenue and Gross Margin (2018-2023)
6.26.4 Lonza Group Immuno-oncology Drugs Product Portfolio
6.26.5 Lonza Group Recent Developments/Updates
6.27 Bio-Rad Laboratories, Inc.
6.27.1 Bio-Rad Laboratories, Inc. Corporation Information
6.27.2 Bio-Rad Laboratories, Inc. Immuno-oncology Drugs Description and Business Overview
6.27.3 Bio-Rad Laboratories, Inc. Immuno-oncology Drugs Sales, Revenue and Gross Margin (2018-2023)
6.27.4 Bio-Rad Laboratories, Inc. Immuno-oncology Drugs Product Portfolio
6.27.5 Bio-Rad Laboratories, Inc. Recent Developments/Updates
6.28 Avantor, Inc.
6.28.1 Avantor, Inc. Corporation Information
6.28.2 Avantor, Inc. Immuno-oncology Drugs Description and Business Overview
6.28.3 Avantor, Inc. Immuno-oncology Drugs Sales, Revenue and Gross Margin (2018-2023)
6.28.4 Avantor, Inc. Immuno-oncology Drugs Product Portfolio
6.28.5 Avantor, Inc. Recent Developments/Updates
6.29 Spring Bank Pharmaceuticals, Inc.
6.29.1 Spring Bank Pharmaceuticals, Inc. Corporation Information
6.29.2 Spring Bank Pharmaceuticals, Inc. Immuno-oncology Drugs Description and Business Overview
6.29.3 Spring Bank Pharmaceuticals, Inc. Immuno-oncology Drugs Sales, Revenue and Gross Margin (2018-2023)
6.29.4 Spring Bank Pharmaceuticals, Inc. Immuno-oncology Drugs Product Portfolio
6.29.5 Spring Bank Pharmaceuticals, Inc. Recent Developments/Updates
6.30 Ferring Pharmaceuticals
6.30.1 Ferring Pharmaceuticals Corporation Information
6.30.2 Ferring Pharmaceuticals Immuno-oncology Drugs Description and Business Overview
6.30.3 Ferring Pharmaceuticals Immuno-oncology Drugs Sales, Revenue and Gross Margin (2018-2023)
6.30.4 Ferring Pharmaceuticals Immuno-oncology Drugs Product Portfolio
6.30.5 Ferring Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Immuno-oncology Drugs Industry Chain Analysis
7.2 Immuno-oncology Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Immuno-oncology Drugs Production Mode & Process
7.4 Immuno-oncology Drugs Sales and Marketing
7.4.1 Immuno-oncology Drugs Sales Channels
7.4.2 Immuno-oncology Drugs Distributors
7.5 Immuno-oncology Drugs Customers
8 Immuno-oncology Drugs Market Dynamics
8.1 Immuno-oncology Drugs Industry Trends
8.2 Immuno-oncology Drugs Market Drivers
8.3 Immuno-oncology Drugs Market Challenges
8.4 Immuno-oncology Drugs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Immuno-oncology Drugs Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Immuno-oncology Drugs Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Immuno-oncology Drugs Market Competitive Situation by Manufacturers in 2022
Table 4. Global Immuno-oncology Drugs Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Immuno-oncology Drugs Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Immuno-oncology Drugs Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Immuno-oncology Drugs Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Immuno-oncology Drugs Average Price (USD/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Immuno-oncology Drugs, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Immuno-oncology Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Immuno-oncology Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Immuno-oncology Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Immuno-oncology Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immuno-oncology Drugs as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Immuno-oncology Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Immuno-oncology Drugs Sales by Region (2018-2023) & (K Units)
Table 18. Global Immuno-oncology Drugs Sales Market Share by Region (2018-2023)
Table 19. Global Immuno-oncology Drugs Sales by Region (2024-2029) & (K Units)
Table 20. Global Immuno-oncology Drugs Sales Market Share by Region (2024-2029)
Table 21. Global Immuno-oncology Drugs Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Immuno-oncology Drugs Revenue Market Share by Region (2018-2023)
Table 23. Global Immuno-oncology Drugs Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Immuno-oncology Drugs Revenue Market Share by Region (2024-2029)
Table 25. North America Immuno-oncology Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Immuno-oncology Drugs Sales by Country (2018-2023) & (K Units)
Table 27. North America Immuno-oncology Drugs Sales by Country (2024-2029) & (K Units)
Table 28. North America Immuno-oncology Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Immuno-oncology Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Immuno-oncology Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Immuno-oncology Drugs Sales by Country (2018-2023) & (K Units)
Table 32. Europe Immuno-oncology Drugs Sales by Country (2024-2029) & (K Units)
Table 33. Europe Immuno-oncology Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Immuno-oncology Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Immuno-oncology Drugs Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Immuno-oncology Drugs Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Immuno-oncology Drugs Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Immuno-oncology Drugs Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Immuno-oncology Drugs Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Immuno-oncology Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Immuno-oncology Drugs Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Immuno-oncology Drugs Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Immuno-oncology Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Immuno-oncology Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Immuno-oncology Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Immuno-oncology Drugs Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Immuno-oncology Drugs Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Immuno-oncology Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Immuno-oncology Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Immuno-oncology Drugs Sales (K Units) by Type (2018-2023)
Table 51. Global Immuno-oncology Drugs Sales (K Units) by Type (2024-2029)
Table 52. Global Immuno-oncology Drugs Sales Market Share by Type (2018-2023)
Table 53. Global Immuno-oncology Drugs Sales Market Share by Type (2024-2029)
Table 54. Global Immuno-oncology Drugs Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Immuno-oncology Drugs Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Immuno-oncology Drugs Revenue Market Share by Type (2018-2023)
Table 57. Global Immuno-oncology Drugs Revenue Market Share by Type (2024-2029)
Table 58. Global Immuno-oncology Drugs Price (USD/Unit) by Type (2018-2023)
Table 59. Global Immuno-oncology Drugs Price (USD/Unit) by Type (2024-2029)
Table 60. Global Immuno-oncology Drugs Sales (K Units) by Application (2018-2023)
Table 61. Global Immuno-oncology Drugs Sales (K Units) by Application (2024-2029)
Table 62. Global Immuno-oncology Drugs Sales Market Share by Application (2018-2023)
Table 63. Global Immuno-oncology Drugs Sales Market Share by Application (2024-2029)
Table 64. Global Immuno-oncology Drugs Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Immuno-oncology Drugs Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Immuno-oncology Drugs Revenue Market Share by Application (2018-2023)
Table 67. Global Immuno-oncology Drugs Revenue Market Share by Application (2024-2029)
Table 68. Global Immuno-oncology Drugs Price (USD/Unit) by Application (2018-2023)
Table 69. Global Immuno-oncology Drugs Price (USD/Unit) by Application (2024-2029)
Table 70. Amgen, Inc Corporation Information
Table 71. Amgen, Inc Description and Business Overview
Table 72. Amgen, Inc Immuno-oncology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 73. Amgen, Inc Immuno-oncology Drugs Product
Table 74. Amgen, Inc Recent Developments/Updates
Table 75. AstraZeneca, Plc Corporation Information
Table 76. AstraZeneca, Plc Description and Business Overview
Table 77. AstraZeneca, Plc Immuno-oncology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 78. AstraZeneca, Plc Immuno-oncology Drugs Product
Table 79. AstraZeneca, Plc Recent Developments/Updates
Table 80. Bristol-Myers Squibb Corporation Information
Table 81. Bristol-Myers Squibb Description and Business Overview
Table 82. Bristol-Myers Squibb Immuno-oncology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 83. Bristol-Myers Squibb Immuno-oncology Drugs Product
Table 84. Bristol-Myers Squibb Recent Developments/Updates
Table 85. Celgene Corporation Corporation Information
Table 86. Celgene Corporation Description and Business Overview
Table 87. Celgene Corporation Immuno-oncology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 88. Celgene Corporation Immuno-oncology Drugs Product
Table 89. Celgene Corporation Recent Developments/Updates
Table 90. Eli Lilly and Company Corporation Information
Table 91. Eli Lilly and Company Description and Business Overview
Table 92. Eli Lilly and Company Immuno-oncology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 93. Eli Lilly and Company Immuno-oncology Drugs Product
Table 94. Eli Lilly and Company Recent Developments/Updates
Table 95. Merck & Co. Corporation Information
Table 96. Merck & Co. Description and Business Overview
Table 97. Merck & Co. Immuno-oncology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 98. Merck & Co. Immuno-oncology Drugs Product
Table 99. Merck & Co. Recent Developments/Updates
Table 100. Hoffmann-La Roche AG Corporation Information
Table 101. Hoffmann-La Roche AG Description and Business Overview
Table 102. Hoffmann-La Roche AG Immuno-oncology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 103. Hoffmann-La Roche AG Immuno-oncology Drugs Product
Table 104. Hoffmann-La Roche AG Recent Developments/Updates
Table 105. Johnson & Johnson Corporation Information
Table 106. Johnson & Johnson Description and Business Overview
Table 107. Johnson & Johnson Immuno-oncology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 108. Johnson & Johnson Immuno-oncology Drugs Product
Table 109. Johnson & Johnson Recent Developments/Updates
Table 110. Novartis International AG Corporation Information
Table 111. Novartis International AG Description and Business Overview
Table 112. Novartis International AG Immuno-oncology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 113. Novartis International AG Immuno-oncology Drugs Product
Table 114. Novartis International AG Recent Developments/Updates
Table 115. AbbVie, Inc. Corporation Information
Table 116. AbbVie, Inc. Description and Business Overview
Table 117. AbbVie, Inc. Immuno-oncology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 118. AbbVie, Inc. Immuno-oncology Drugs Product
Table 119. AbbVie, Inc. Recent Developments/Updates
Table 120. Pfizer Inc. Corporation Information
Table 121. Pfizer Inc. Description and Business Overview
Table 122. Pfizer Inc. Immuno-oncology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 123. Pfizer Inc. Immuno-oncology Drugs Product
Table 124. Pfizer Inc. Recent Developments/Updates
Table 125. Sanofi S.A. Corporation Information
Table 126. Sanofi S.A. Description and Business Overview
Table 127. Sanofi S.A. Immuno-oncology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 128. Sanofi S.A. Immuno-oncology Drugs Product
Table 129. Sanofi S.A. Recent Developments/Updates
Table 130. EMD Serono, Inc. Corporation Information
Table 131. EMD Serono, Inc. Description and Business Overview
Table 132. EMD Serono, Inc. Immuno-oncology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 133. EMD Serono, Inc. Immuno-oncology Drugs Product
Table 134. EMD Serono, Inc. Recent Developments/Updates
Table 135. Gilead Sciences Inc. Corporation Information
Table 136. Gilead Sciences Inc. Description and Business Overview
Table 137. Gilead Sciences Inc. Immuno-oncology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 138. Gilead Sciences Inc. Immuno-oncology Drugs Product
Table 139. Gilead Sciences Inc. Recent Developments/Updates
Table 140. Prometheus Therapeutics & Diagnostics Corporation Information
Table 141. Prometheus Therapeutics & Diagnostics Description and Business Overview
Table 142. Prometheus Therapeutics & Diagnostics Immuno-oncology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 143. Prometheus Therapeutics & Diagnostics Immuno-oncology Drugs Product
Table 144. Prometheus Therapeutics & Diagnostics Recent Developments/Updates
Table 145. Aduro BioTech Corporation Information
Table 146. Aduro BioTech Description and Business Overview
Table 147. Aduro BioTech Immuno-oncology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 148. Aduro BioTech Immuno-oncology Drugs Product
Table 149. Aduro BioTech Recent Developments/Updates
Table 150. Galena Biopharma Corporation Information
Table 151. Galena Biopharma Description and Business Overview
Table 152. Galena Biopharma Immuno-oncology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 153. Galena Biopharma Immuno-oncology Drugs Product
Table 154. Galena Biopharma Recent Developments/Updates
Table 155. Bavarian Nordic Corporation Information

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Analytical Standards Market Insights: Impact of COVID-19 and Future Expectations to 2028

Published: 16-Mar-2023        Price: US 3260 Onwards        Pages: 108

The Analytical Standards market revenue was 2055.18 Million USD in 2022, and will reach 3275.31 Million USD in 2028, with a CAGR of 8.08% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the Analytical Standards industry, and breaks down according to the type, application, and consumption area of Analytical Standards. The report also introduces players in the industry from the perspective of the industry chain and marketing cha......

Global Human Serum Albumin Market Insights: Impact of COVID-19 and Future Expectations to 2028

Published: 16-Mar-2023        Price: US 3260 Onwards        Pages: 105

The Human Serum Albumin market revenue was XX Million USD in 2022, and will reach XX Million USD in 2028, with a CAGR of XX% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the Human Serum Albumin industry, and breaks down according to the type, application, and consumption area of Human Serum Albumin. The report also introduces players in the industry from the perspective of the industry chain and marketing chain and describe......

Global Pharmaceutical Market Insights: Impact of COVID-19 and Future Expectations to 2028

Published: 16-Mar-2023        Price: US 3260 Onwards        Pages: 107

The Pharmaceutical market revenue was XX Million USD in 2022, and will reach XX Million USD in 2028, with a CAGR of XX% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the Pharmaceutical industry, and breaks down according to the type, application, and consumption area of Pharmaceutical. The report also introduces players in the industry from the perspective of the industry chain and marketing chain and describes the leading c......

Global Human Albumin Market Insights: Impact of COVID-19 and Future Expectations to 2028

Published: 16-Mar-2023        Price: US 3260 Onwards        Pages: 129

The Human Albumin market revenue was XX Million USD in 2022, and will reach XX Million USD in 2028, with a CAGR of XX% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the Human Albumin industry, and breaks down according to the type, application, and consumption area of Human Albumin. The report also introduces players in the industry from the perspective of the industry chain and marketing chain and describes the leading comp......

Global Softgel Capsules Market Insights: Impact of COVID-19 and Future Expectations to 2028

Published: 16-Mar-2023        Price: US 3260 Onwards        Pages: 103

The Softgel Capsules market revenue was 9672.28 Million USD in 2022, and will reach 15017.42 Million USD in 2028, with a CAGR of 7.61% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the Softgel Capsules industry, and breaks down according to the type, application, and consumption area of Softgel Capsules. The report also introduces players in the industry from the perspective of the industry chain and marketing chain and desc......

Global Soft Gelatin Capsules Market Insights: Impact of COVID-19 and Future Expectations to 2028

Published: 16-Mar-2023        Price: US 3260 Onwards        Pages: 120

Soft gelatin capsules, also known as soft gels, are still the leading product format in dietary supplements. Soft gelatin capsules is ideal for both the dietary supplement and pharmaceutical markets The Soft Gelatin Capsules market revenue was 4377.06 Million USD in 2022, and will reach 6272.58 Million USD in 2028, with a CAGR of 6.18% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the Soft Gelatin Capsules industry, a......

Global Pharma & Cosmetics Market Insights: Impact of COVID-19 and Future Expectations to 2028

Published: 16-Mar-2023        Price: US 3260 Onwards        Pages: 101

The Pharma & Cosmetics market revenue was 1863641.54 Million USD in 2022, and will reach 2263346.26 Million USD in 2028, with a CAGR of 3.29% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the Pharma & Cosmetics industry, and breaks down according to the type, application, and consumption area of Pharma & Cosmetics. The report also introduces players in the industry from the perspective of the industry chain and marketing cha......

Global Oncology (Anti-cancer Drugs) Market Research Report 2023

Published: 16-Mar-2023        Price: US 2900 Onwards        Pages: 91

Highlights The global Oncology (Anti-cancer Drugs) market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes. North American market for Oncology (Anti-cancer Drugs) is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 202......

Global Pigskin Gelatin Market Research Report 2023

Published: 16-Mar-2023        Price: US 2900 Onwards        Pages: 113

Gelatin is a protein obtained by boiling skin, tendons, ligaments, and/or bones with water. It is usually obtained from cows or pigs. Skin gelatin is made of fresh animal skin. Highlights The global Pigskin Gelatin market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes. The rese......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs